Most Expensive Cancer Drug Treatments
New cancer drugs, especially those for rare conditions or advanced therapies, often come with exceptionally high price tags, making them some of the most expensive medications available.
The top 3
- Top 3 Most Expensive Cancer Drugs (Annual/One-time Cost): Some of the most expensive cancer-related drugs include Zolgensma (a gene therapy for spinal muscular atrophy, $2.1 million one-time), Kimmtrak for uveal melanoma ($975,520 annually), and Danyelza for neuroblastoma ($977,664 annually).
- Factors Driving High Cancer Drug Costs: High cancer drug prices are driven by specialized and expensive research and development (median $648 million per drug), high clinical trial failure rates (97% for oncology drugs), and lack of competition due to patent protection.
- New Pancreatic Drug's High Price Tag: The newly approved pancreatic cancer drug, Rasonque, carries a list price of over $475,000 per year, making it one of the most expensive cancer treatments.
Sources
Open the full topic